Koninklijke Philips NV
A Dutch health technology company that makes MRI and CT scanners, ventilators, and sleep-care devices used in hospitals and homes. It began in 1891 in Eindhoven, when engineer Gerard Philips and his banker father Frederik started making carbon-filament light bulbs, naming the firm after their family. A fun quirk: until 1912 the Netherlands had no patent law, so the young company freely studied rivals' bulb designs to build its own factory.
New York Registry Shares
Item 4 is hereby amended and supplemented by the addition of the following: On August 10, 2026, the Issuer and Exor entered into an amendment to the Relationship Agreement (the "Amended Relationship Agreement") that increased the legal and beneficial ownership limit from 20.0% to 22.0% of the issued outstanding ordinary share and voting rights that Exor and its affiliates are permitted to acquire under the Amended Relationship Agreement. The foregoing description of the Amended Relationship Agreement is qualified in its entirety by reference to the full text of the Amended Relationship Agreement, which is incorporated by reference as Exhibit 99.2 and is incorporated herein by reference.
Item 4 is hereby amended and supplemented by the addition of the following: On August 10, 2026, the Issuer and Exor entered into an amendment to the Relationship Agreement (the "Amended Relationship Agreement") that increased the legal and beneficial ownership limit from 20.0% to 22.0% of the issued outstanding ordinary share and voting rights that Exor and its affiliates are permitted to acquire under the Amended Relationship Agreement. The foregoing description of the Amended Relationship Agreement is qualified in its entirety by reference to the full text of the Amended Relationship Agreement, which is incorporated by reference as Exhibit 99.2 and is incorporated herein by reference.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| Giovanni Agnelli B.V. | 13D/AActivist | 19.03% | 185.93M | Aug 21, 2026 |
Item 4 is hereby amended and supplemented by the addition of the following: On August 10, 2026, the Issuer and Exor entered into an amendment to the Relationship Agreement (the "Amended Relationship Agreement") that increased the legal and beneficial ownership limit from 20.0% to 22.0% of the issued outstanding ordinary share and voting rights that Exor and its affiliates are permitted to acquire under the Amended Relationship Agreement. The foregoing description of the Amended Relationship Agreement is qualified in its entirety by reference to the full text of the Amended Relationship Agreement, which is incorporated by reference as Exhibit 99.2 and is incorporated herein by reference. | ||||
| Exor N.V. | 13D/AActivist | 19.03% | 185.93M | Aug 21, 2026 |
Item 4 is hereby amended and supplemented by the addition of the following: On August 10, 2026, the Issuer and Exor entered into an amendment to the Relationship Agreement (the "Amended Relationship Agreement") that increased the legal and beneficial ownership limit from 20.0% to 22.0% of the issued outstanding ordinary share and voting rights that Exor and its affiliates are permitted to acquire under the Amended Relationship Agreement. The foregoing description of the Amended Relationship Agreement is qualified in its entirety by reference to the full text of the Amended Relationship Agreement, which is incorporated by reference as Exhibit 99.2 and is incorporated herein by reference. | ||||
| BlackRock, Inc. | 13G/APassive | 4.4% | 41.23M | Apr 29, 2025 |